1. Ozols RF, Corden BJ, Collins J, Young RC. 1983. Renal effects and clinical pharmacokinetics of high-dose (HD) cisplatin (P) (40 mg/m QD × 5) in hypertonic saline. 4th Intl. Symp. Platinum Coord. Complexes Cancer Chemother. C-II, p. 75.
2. Hrushesky W, Cornelissen G, Halberg F, De Prins J, Nesbitt M, Kennedy BJ. 1978. Rhythm parameters of experimental data on carcinostatics potentially applicable to clinical chronotherapy. Proc. MN Academy Science 46:22.
3. Hrushesky WJM. 1983, in press. Chemotherapy timing: an important variable in toxicity and response. In: M Perry and J Yarbro (eds), Toxicity of Chemotherapy. New York, Grune & Stratton, Inc.
4. Hrushesky WJ, Levi FA, Halberg F, Kennedy BJ. 1982. Circadian stage dependence of cis-diamminedichloroplatinum lethal toxicity in rats. Cancer Res. 42:945–949.
5. Levi F, Hrushesky W, Borch R, Pleasants M, Kennedy BJ, Halberg F. 1982. Cisplatin urinary pharmacokinetics and nephrotoxicity: a common circadian mechanism. Cancer Treat. Rep. 66(#11): 1933–1938.